Imlunestrant with or without Abemaciclib in Advanced Breast Cancer.
AuteursJhaveri KL, Neven P, Casalnuovo ML, Kim SB, Tokunaga E, Aftimos P, Saura C, O'Shaughnessy J, Harbeck N, Carey LA, Curigliano G, Llombart-Cussac A, Lim E, García Tinoco ML, Sohn J, Mattar A, Zhang Q, Huang CS, Hung CC, Martinez Rodriguez JL, Ruíz Borrego M, Nakamura R, Pradhan KR, Cramer von Laue C, Barrett E, Cao S, Wang XA, Smyth LM, Bidard FC
Effects of very early hyperoxemia on neurologic outcome after out-of-hospital cardiac arrest: A secondary analysis of the TTM-2 trial.
AuteursSanfilippo F, Uryga A, Santonocito C, Jakobsen JC, Lilja G, Friberg H, Wendel-Garcia PD, Young PJ, Eastwood G, Chew MS, Unden J, Thomas M, Grejs AM, Wise MP, Lundin A, Hollenberg J, Hammond N, Saxena M, Martin A, Bánszky R, Taccone FS, Dankiewicz J, Nielsen N, Ebner F, BeloholaveK J, Hanggi M, Montagnani L, Patroniti N, Robba C
An international and multidisciplinary EORTC survey on resectability of stage III non-small cell lung cancer.
AuteursHouda I, Bahce I, Dickhoff C, Kroese TE, Kroeze SGC, Mariolo AV, Tagliamento M, Moliner L, Brandão M, Pretzenbacher Y, Edwards J, Opitz I, Brunelli A, Guckenberger M, van Schil PE, Popat S, Blum T, Faivre-Finn C, de Ruysscher D, Remon J, Berghmans T, Dingemans AC, Besse B, Hendriks LEL